T Cell Genesis: In Vitro Veritas Est?

Area of Science:

• Immunology
• Stem Cell Biology
• Cell Therapy

Background:

• T cells orchestrate adaptive immunity and are crucial for cancer immunotherapy.
• Clinical application of T cells is limited by low yields of antigen-specific cells.
• In vitro generation of T cells from stem cells presents a scalable alternative.

Purpose of the Study:

• To review strategies for generating T cells from human hematopoietic stem/progenitor cells (HSPCs) and pluripotent stem cells (PSCs) in vitro.
• To highlight the potential of in vitro T cell generation for therapeutic applications.

Main Methods:

• Review of recent scientific literature on T cell generation from HSPCs and PSCs.
• Discussion of methods for large-scale production and genetic manipulation of T cells.

Main Results:

• In vitro generation from HSPCs and PSCs enables large-scale T cell production.
• This approach facilitates genetic modification of T cells for enhanced therapeutic efficacy.

Conclusions:

• Advancements in in vitro T cell generation from stem cells are expanding therapeutic potential.
• This technology promises to overcome current limitations in T cell-based therapies, particularly in cancer immunotherapy.